Michael Platten, lead author the previous study on this topic. Professor plates is a Senior Consultant in the Department of Neuro-Oncology at the University Hospital and the director of the Helmholtz-University Young Investigators Group Experimental Neuroimmunology at the German Cancer Research Center in Heidelberg.. Pressure. Sclerosis treatment with antihypertensive drugresearchers in Heidelberg and Stanford have discovered a new signaling pathway of brain cells, how widespread antihypertensive drugs could keep inflammation in multiple sclerosis in chess, explains. The peptide angiotensin not only raises blood pressure but also activates the immunological messenger substance TGF beta on a previously unknown communication in the brain.
Source: Prof.Lupus is a significant cost to employers, according to Thomson Reuters StudyA study in the Journal of Occupational and Environmental Medicine (published found that the mean annual price tag for lupus – including medical expenditures, time away from work, and short-term disability costs – was almost $ 20,000 per patient, the average cost rose to more than $ 60,000 per patient for lupus through the kidney disease nephritis was accompanied , as is often the case that more than the average annual cost of other chronic diseases like diabetes, heart disease, rheumatoid arthritis and chronic obstructive pulmonary disease.Participants the combined treatment Been about 2.5 times more frequently than those not to treating with depression reflectivity. Nearly 40 % of fully fully adherent to the in remission in remission 3 months, when only 12 % respondents were not in the treatment of in remission at this time.
The study is published in the February 2004 issue the British Journal of Psychiatry. There was partly financed by NIDA.